(Total Views: 206)
Posted On: 09/15/2021 6:52:42 AM
Post# of 6
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
AKBA let's see if we get share price appreciation as we get closer to FDA approval for the blockbuster drug Vadadustat for anemia on
03/29/22 for dialysis patients and more importantly non dialysis patients.! AKBA bulls let's accumulate under $3.00 for a move to $12-15 range after FDA approval for Vadadustat!
03/29/22 for dialysis patients and more importantly non dialysis patients.! AKBA bulls let's accumulate under $3.00 for a move to $12-15 range after FDA approval for Vadadustat!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)